2, 3-Butanedione-2-monoxime nitidine 7R)-3-[(acetyloxy)methyl]-7-[(2R)-2-amino-2-phenylacetamido]-6-hydrogenio-8-oxo-5-thia-1-azabicyclo[4

7R)-3-[(acetyloxy)methyl]-7-[(2R)-2-amino-2-phenylacetamido]-6-hydrogenio-8-oxo-5-thia-1-azabicyclo[4

5 μΜ for cellular pDNA-PK

D-AP5 causes sensorimotor disturbances in the spatial task

org/wiki/Valsartan/sacubitril)

2, 3-Butanedione-2-monoxime nitidine 7R)-3-[(acetyloxy)methyl]-7-[(2R)-2-amino-2-phenylacetamido]-6-hydrogenio-8-oxo-5-thia-1-azabicyclo[42,3 Butanedione 2 monoxime is a myosin ATPase inhibitor. Myosin, an ATPase, can convert chemical energy into directed movement and is regarded as a molecular motor. Myosin has various shapes and sizes. More than 11 myosin classes have been identified, and more will be found. The common feature of all of these molecules is a section close to the N terminus, which can be identified as a motor domain. In vitro: 2,3 Butanedione 2 monoxime (BDM), a general